Detalles de la búsqueda
1.
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
Future Oncol
; 17(16): 1987-2003, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33682447
2.
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial.
Br J Haematol
; 179(1): 66-74, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28653400
3.
A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors.
Invest New Drugs
; 31(4): 974-85, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23377661
4.
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression.
Leuk Lymphoma
; 64(12): 1992-2001, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37571998
5.
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
J Clin Oncol
; 41(15): 2682-2690, 2023 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37196429
6.
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML.
Blood Adv
; 7(9): 1858-1870, 2023 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477975
7.
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
J Clin Oncol
; 22(9): 1589-97, 2004 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15117980
8.
The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
Stat Med
; 27(28): 5850-60, 2008 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18759373
9.
Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
J Thorac Oncol
; 2(5): 397-401, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17473654
10.
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer.
J Clin Oncol
; 24(27): 4405-11, 2006 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16983108
Resultados
1 -
10
de 10
1
Próxima >
>>